AMNEAL PHARMACEUTICALS, INC. Proceeds from Life Insurance Policy
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Proceeds from Life Insurance Policy of $1.00 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLifeInsurancePolicies · last filed 2022-11-07
- AMNEAL PHARMACEUTICALS, INC. proceeds from life insurance policy for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- AMNEAL PHARMACEUTICALS, INC. proceeds from life insurance policy for fiscal 2019 was $43.02M.
- AMNEAL PHARMACEUTICALS, INC. proceeds from life insurance policy for fiscal 2018 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. proceeds from life insurance policy for fiscal 2017 was $0.00.
| Period end | Proceeds from Life Insurance Policy 1 month | Proceeds from Life Insurance Policy 6 month | Proceeds from Life Insurance Policy 9 month | Proceeds from Life Insurance Policy 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.00M 10-Q · filed 2022-11-07 | |||
| 2022-06-30 | $1.00M 10-Q · filed 2022-08-08 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 | |||
| 2019-12-31 | $43.02M 10-K · filed 2021-03-01 | |||
| 2019-09-30 | $43.02M 10-Q · filed 2020-11-06 | |||
| 2019-07-31 | $43.00M 10-K · filed 2020-03-02 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |